Effect of add-on medication (with dose increase, combined with anti-leukotriene , combined with steroid nasal spray)for allergic rhinitis patients who are not effective of normal dose of Bepotastine besilate .

Effect of add-on medication (with dose increase, combined with anti-leukotriene , combined with steroid nasal spray)for allergic rhinitis patients who are not effective of normal dose of Bepotastine besilate . - Effect of add-on medication (with dose increase, combined with anti-leukotriene , combined with steroid nasal spray)for allergic rhinitis patients who are not effective of normal dose of Bepotastine besilate .

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011336

Enrollment

150

Registered

2013-10-01

Start date

2013-09-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

1Double dose , 2used together with anti leuotorien,3used together with steroid nasal spray

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: allergoc rhinitis

Exclusion criteria

Exclusion criteria: Patients judged inappropriate for this study by the physicians

Design outcomes

Primary

Measure	Time frame
Assesment of symptom after as below for the allergic rhinitis patients . Allergic rhinitis patients are separeted 3groups(dose increase,combined with anti-luekotriene, combined with steroid nasal spray) ,and carry on for 4 week. Assesment:medical examination at the department of otorhinolaryngology with a disease questionnaire.	—

Countries

Japan

Contacts

Public ContactNibu Keni-chi

Kobe University Graduate Scool of Medicine Department of otorhinolaryngology Head and Neck Surgery

nibu@med.kobe-u.ac.jp81-78-382-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026